Skip to main content

OsiriX

SoftwareGeneva, SwitzerlandFounded 2022· One of 361 Software companies tracked by AMPulse

DICOM medical imaging software with advanced 2D/3D/4D/5D visualization and post-processing capabilities, enabling creation of 3D printable models from medical scans

CEO / Founder
Antoine Rosset
Team Size
1-10
Stage
Active
Total Funding
Undisclosed
Latest Round
No known funding rounds

Technology & Products

Key Products

OsiriX MD (certified medical device); OsiriX Lite (free demo version); Dental3DPlugin for implant planning and surgical guide 3D printing

Technological Advantage

Proprietary 64-bit multithreaded architecture for handling unlimited medical images with ultrafast 3D rendering; ISO 13485 certification as medical device manufacturer; FDA-cleared/CE-certified for clinical use

Differentiation

Value Proposition

Provides FDA-cleared/CE-certified DICOM viewer (OsiriX MD) for clinical diagnosis and free version (OsiriX Lite) for research, with plugins enabling 3D model export for medical 3D printing applications like surgical guides and anatomical models

How They Differentiate

MacOS-native with Apple Design Award pedigree vs. cross-platform competitors; FDA/CE-certified clinical version vs. research-only alternatives; specific plugins for dental 3D printing vs. general DICOM viewers

Market & Competition

Target Customers

Radiologists, medical researchers, hospitals, universities, dental professionals

Industry Verticals

Medical; Healthcare; Research; Dental

Competitors

Horos; SoftDicom; D2P (3D Systems); 3Dicom Viewer; MiNNOVAA

Growth & Milestones

Growth Metrics

Estimated $5.6M annual revenue; approximately 20-29 employees; used by thousands of medical professionals worldwide

Major Milestones

2004: OsiriX project started at UCLA; 2005: Won two Apple Design Awards at WWDC; 2010: Pixmeo founded, launched OsiriX MD as certified medical device; 2015: Celebrated 10 years of OsiriX platform technology